Loading stock analysis…
Evidence Synthesis
Last synthesized: 22 Jul 2026, 13:58
Evidence Synthesis
JOHNPHARMA experienced a 100% gross margin, accelerating from -2600.97%.
The company's marginal operating leverage declined. In terms of volume, DAILY_VOLUME decreased to 315,407 shares, a drop of 53,792 shares from the previous day. The close price declined from 0.48 INR.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 100 % | -2,600.97 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -2,600.97 % | 0 | ▼ |
| PRICE_CHANGE_PERCENT | -2.041 % | — | - |
| DAILY_VOLUME | 3,15,407 shares | 6,91,799 | ▼ |
| CLOSE_PRICE | 0.47 INR | 0.48 | ▼ |